Helus Pharma Inc.(HELP)

Medical - Pharmaceuticals · Toronto, ON

$10.76-0.66 (-5.78%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T21:51:55.603Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:51:55.603Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 10.76
Unrounded diluted TTM EPS · period ending 2026-06-30: -5.51

FMP input reference: 934548bd97ab8c390298f716fcf622fc2d1107cfab085c47b2b47650fd31fbc6

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

HELP PE Ratio Metrics

PE RATIO

N/A

HELP Competitors' PE Ratio

HELP

Helus Pharma Inc.

Current

Market Cap

$666.95M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDXG

MiMedx Group, Inc.

vs HELP

Market Cap

$673.41M

PE Ratio

115.50

TTM Avg

37.43

3Y Avg

206.22

5Y Avg

206.22

ANNX

Annexon, Inc.

vs HELP

Market Cap

$660.29M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

STLN

Starling Oncology, Inc.

vs HELP

Market Cap

$657.89M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FDMT

4D Molecular Therapeutics, Inc.

vs HELP

Market Cap

$656.59M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VSTM

Verastem, Inc.

vs HELP

Market Cap

$681.02M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SLDB

Solid Biosciences Inc.

vs HELP

Market Cap

$681.27M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AVR

Anteris Technologies Global Corp.

vs HELP

Market Cap

$685.49M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OLMA

Olema Pharmaceuticals, Inc.

vs HELP

Market Cap

$691.79M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FTH

Faeth Therapeutics, Inc.

vs HELP

Market Cap

$693.19M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Helus Pharma Inc. (HELP)	$666.95M	N/A	N/A	N/A	N/A
MiMedx Group, Inc. (MDXG)vs ›	$673.41M	115.50	37.43	206.22	206.22
Annexon, Inc. (ANNX)vs ›	$660.29M	N/A	N/A	N/A	N/A
Starling Oncology, Inc. (STLN)vs ›	$657.89M	N/A	N/A	N/A	N/A
4D Molecular Therapeutics, Inc. (FDMT)vs ›	$656.59M	N/A	N/A	N/A	N/A
Verastem, Inc. (VSTM)vs ›	$681.02M	N/A	N/A	N/A	N/A
Solid Biosciences Inc. (SLDB)vs ›	$681.27M	N/A	N/A	N/A	N/A
Anteris Technologies Global Corp. (AVR)vs ›	$685.49M	N/A	N/A	N/A	N/A
Olema Pharmaceuticals, Inc. (OLMA)vs ›	$691.79M	N/A	N/A	N/A	N/A
Faeth Therapeutics, Inc. (FTH)vs ›	$693.19M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

HELP PE Ratio Metrics

HELP Competitors' PE Ratio

P/E Comparison

PE Ratio Formula & Definition

Related Metrics